No headlines found.
Amwell to Report First Quarter 2024 Operating Results May 1
Globe Newswire (Wed, 17-Apr 7:00 AM ET)
Amwell Receives Continued Listing Standard Notice From NYSE
Globe Newswire (Thu, 4-Apr 4:05 PM ET)
Power of Amwell Hybrid Care Solutions to be Highlighted at HIMSS 2024
Globe Newswire (Wed, 6-Mar 6:00 AM ET)
Amwell Names Cynthia Horner, M.D., Chief Medical Officer
Globe Newswire (Thu, 22-Feb 6:00 AM ET)
Amwell Expands Presence in Australia with Amplar Health Partnership
Globe Newswire (Wed, 21-Feb 7:00 AM ET)
Amwell to Participate in Upcoming Investor Conference
Globe Newswire (Wed, 21-Feb 6:00 AM ET)
Amwell Executives to Take the Stage at ViVE 2024
Globe Newswire (Thu, 15-Feb 6:00 AM ET)
Amwell Announces Results for Fourth Quarter and Full Year 2023
Globe Newswire (Wed, 14-Feb 4:05 PM ET)
Amwell to Report Fourth Quarter and Full Year 2023 Operating Results on Feb. 14
Globe Newswire (Wed, 31-Jan 6:00 AM ET)
American Well Corp is a telehealth company enabling digital delivery of care for its customers. Its platform, Amwell, digital care delivery solution that equips health systems, health plans, government, and innovator clients with the tools to enable new models of care for their patients and members enabling care delivery across the full healthcare continuum - from primary and urgent care in the home to high acuity specialty consults, such as telestroke and telepsychiatry, in the hospital. It provides both on-demand and scheduled consultations. Its Health Plan Programs include Virtual Primary Care, Musculoskeletal Care, Dermatology Care, and Chronic Care among others.
American Well Class A trades on the NYSE stock market under the symbol AMWL.
As of April 19, 2024, AMWL stock price climbed to $0.55 with 398,536 million shares trading.
AMWL has a beta of 3.67, meaning it tends to be more sensitive to market movements. AMWL has a correlation of 0.28 to the broad based SPY ETF.
AMWL has a market cap of $159.09 million. This is considered a Micro Cap stock.
Last quarter American Well Class A reported $71 million in Revenue and -$.17 earnings per share. This beat revenue expectation by $477,000 and exceeded earnings estimates by $.03.
In the last 3 years, AMWL stock traded as high as $19.21 and as low as $.50.
The top ETF exchange traded funds that AMWL belongs to (by Net Assets): VTI, VXF, IWM, IWN, VTWO.
AMWL has underperformed the market in the last year with a price return of -73.0% while the SPY ETF gained +21.9%. AMWL has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -48.6% and -31.3%, respectively, while the SPY returned +4.9% and -2.9%, respectively.
AMWL support price is $.49 and resistance is $.55 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that AMWL stock will trade within this expected range on the day.